About this event

  • Date and time Thu 17 Oct 2024 from 8:00am to 18 Oct 2024 at 5:15pm
  • Location Royal Society of Medicine
  • Organised by Partner Symposium, Cleveland Clinic London

Stay at the forefront of cardiovascular disease (CVD) with our two-day seminar bringing together experts from the UK and the US for a state-of-the-art review of the most significant changes, critical updates and recommendations to incorporate into your practice. Attendees can expect updates on cutting-edge science and the implementation of evidence-based guidelines, with the opportunity to network with fellow attendees and renowned speakers. In partnership with Cleveland Clinic’s Heart, Vascular and Thoracic Institute. Free for everyone.

This conference aims to:

  • Apply knowledge to reduce cardiovascular risks through optimal management of dyslipidemia, hypertension, obesity, and diabetes
  • Review the key advances in cardiac electrophysiology, including VT ablation, atrial fibrillation, and syncope and describe their implications for clinical care
  • Apply evidence-based therapies and consensus guidelines for the diagnosis, evaluation, and management across the entire spectrum of patients with heart failure and cardiomyopathy
  • Demonstrate comprehensive, evidence-based care in the evaluation and management of ischemic heart disease, including stable angina
  • Identify prognostic considerations and evaluate treatment options for mitral and aortic valve disease
  • Summarize the key issues in the diagnosis and management of complex aorta disease

Target Audience

This course is designed for general practitioners, consultant cardiologists, cardiac surgeons, nurses, and all medical professionals involved in the management of patients with cardiovascular disease.

Accreditation

In support of improving patient care, Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

American Medical Association (AMA)

Cleveland Clinic Center for Continuing Education designates this live activity for a maximum of 12.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

Certificate of Participation

A certificate of participation will be provided to other healthcare professionals for requesting credits in accordance with their professional boards and/or associations.

Faculty Disclosure

The Cleveland Clinic Foundation Center for Continuing Education has implemented a policy to comply with the current Accreditation Council for Continuing Medical Education Standards for Integrity and Independence requiring mitigation of all faculty conflicts of interest. Faculty declaring a relevant financial relationship will be identified in the activity syllabus.

Cleveland Clinic is nationally ranked and globally recognised as a world leader in cardiovascular care.

Sponsorship and exhibit

For exhibiting or sponsoring this event, please contact Milena Kachar by emailing kacharm@ccf.org

Follow us on:

Facebook 
Instagram
LinkedIn
Twitter
YouTube

Tickets

Standard pricing available until 13 October 2024.

Free for everyone

Member

RSM Member
Day 1 Day 2
£0.00 Day 1 - Prevention, Diagnosis and Management of Cardiovascular Disease 2024: A Contemporary Update
£0.00 Day 2 - Prevention, Diagnosis and Management of Cardiovascular Disease 2024: A Contemporary Update

Non - Member

Non - Member
Day 1 Day 2
£0.00 Day 1 - Prevention, Diagnosis and Management of Cardiovascular Disease 2024: A Contemporary Update
£0.00 Day 2 - Prevention, Diagnosis and Management of Cardiovascular Disease 2024: A Contemporary Update

Agenda

View the provisional programme 17 October 2024

Registration and breakfast

SESSION 1: PREVENTION OF CARDIOVASCULAR DISEASE

Chairs: Bernard Prendergast, Venu Menon 

Panellists: Joan Pattle, Francesca Pugliese

 

Welcome and Announcements
Case scenario: clinical presentation and initial assessment
Tools for risk prediction and cardiovascular prevention: UK, European and US guidelines

Michael Papadakis

CT coronary angiography: seeing is believing

Milind Desai

Beyond statins: new agents, new goals, new targets

Leslie Cho

Obesity, diabetes and cardiorenal risk: new therapies and their implementation

John Deanfield

Hypertension: an old disease with new treatment options

Ian Webb

Case scenario: management strategy and clinical outcome
Panel discussion and Q&A
Coffee break

SESSION 2: VEXING ISSUES IN DAY-TO-DAY PRACTICE

Chairs: Narbeh Melikian, Amanda Vest

Panellists: Ruth Whitby, Michael Papadakis

Case scenario: clinical presentation and initial assessment
Hormone replacement and the heart: who, when and how?

Leslie Cho

Competitive sport: screening of professionals and public for cardiovascular safety

Sanjay Sharma

Cancer and the heart: curative treatment versus cardiac damage

Raj Sharma

Cancer and the lung: advances in early detection and minimally invasive treatment

Carol Tan & Kelvin Lau

A long way from the heart: venous and arterial disease of the legs and feet

Joe Shalhoub & Chung Lim

Case scenario: management strategy and clinical outcome
Panel discussion and Q&A
Lunch

SESSION 3: CORONARY ARTERY DISEASE

Chairs: Jon Byrne, Venu Menon

Panelists: Nick Robinson, Ian Webb

Case scenario: clinical presentation and initial assessment
Optimal detection of coronary artery disease and myocardial ischaemia: an era of multimodality personalized imaging

Milind Desai   

Angina and normal coronary arteries (ANOCA, INOCA, MINOCA): what are we talking about?
Management of stable ischaemic heart disease: who needs revascularisation in 2024?

Simon Kennon

Acute coronary syndromes: key studies underpinning modern management

Mrinal Saha

Stents or surgery: daily decision making for the MDT

Olaf Wendler & Julian Strange

Case scenario: management strategy and clinical outcome
Panel discussion and Q&A
Coffee break

SESSION 4: HEART FAILURE

Chairs: Sanjay Sharma, Brian Halliday

Panellists: George Amin-Youseff, Oussama Wazni

Case scenario: clinical presentation and initial assessment
Beyond echocardiography and BNP: the role of PET and CMR in heart failure diagnosis

Dudley Pennell

Acute heart failure: state of the art

Venu Menon

Chronic heart failure: introduction and optimisation of guideline-directed medical therapy

Amanda Vest

Common co-morbidities and their management: frailty, anemia, sleep apnoea and obesity

Gerry Carr-White

Hypertrophic cardiomyopathy: current concepts in diagnosis and management

Milind Desai

Case scenario: management strategy and clinical outcome
Panel discussion and Q&A
Close
View the provisional programme 18 October 2024

Breakfast

SESSION 5: HEART RHYTHM MANAGEMENT

Chairs: Sabine Ernst, Simon Sporton  

Panellists: Manav Sohal, Tom Wong

Welcome and Announcements
Case scenario: clinical presentation and initial assessment
Atrial arrhythmias: who needs ablation in 2025?

Matt Wright

Prevention of embolic complications: optimal anticoagulation and left atrial appendage closure

Oussama Wazni

Ventricular arrhythmias: new approaches to diagnosis, assessment and treatment

Magdi Saba

Sudden cardiac death: prediction and prevention

Pier Lambiase

Pacing and lead management: new frontiers

Aldo Rinaldi

Case scenario: management strategy and clinical outcome
Panel discussion and Q&A
Coffee break

SESSION 6: VALVE DISEASE I – DIAGNOSIS AND SURVEILLANCE

Chairs: Brian Griffin, Guy Lloyd

Panellists: Mike Bellamy, Sanjeev Battacharya

Case scenario: clinical presentation and initial assessment
Aortic stenosis: challenges in diagnosis and quantification

Bushra Rana

Moderate and asymptomatic severe aortic stenosis: emerging indications for intervention

Samir Kapadia

Primary mitral regurgitation: epidemiology, early diagnosis and early referral

Venu Menon

Secondary and tertiary mitral regurgitation: imaging is the key to successful management

Jim Newton

Tricuspid regurgitation: overlooked and under-treated

Sam Dawkins

Case scenario: management strategy and clinical outcome
Panel discussion and Q&A
Lunch

SESSION 7: VALVE DISEASE II - TRANSCATHETER INTERVENTION AND SURGERY

Chairs: Simon Redwood, Gianluca Lucchese

Panellists: Simon Kennon, Jim Newton

Case scenario: clinical presentation and initial assessment
Transcatheter aortic valve implantation: innovation and evolution

Samir Kapadia

Transcatheter mitral and tricuspid edge-to-edge repair: lessons from recent trials

Tiffany Patterson

Modern valve surgery: staying ahead of the game

Marc Gillinov

Multi-valve disease: a surgical perspective

Max Baghai

Concomitant atrial fibrillation: surgical strategies

Ranjit Deshpande

Case scenario: management strategy and clinical outcome
Panel discussion and Q&A
Coffee break

SESSION 8: COMPLEX DISEASE OF THE AORTA

Chairs: Olaf Wendler, Marc Gillinov

Panellists: Mark Tyrell, Ranjit Deshpande

Case scenario: clinical presentation and initial assessment
Inherited disease of the aorta: who needs genetic screening?

Guy Lloyd

Bicuspid aortic valve disease: the role of multimodality imaging

Milind Desai

The root and ascending aorta: advances in surgery

Olaf Wendler

The arch and thoraco-abdominal aorta: advances in surgery

Aung Oo

Beyond surgery: interventional and hybrid approaches

Jason Wilkins

Case scenario: management strategy and clinical outcome
Panel discussion and Q&A
Closing remarks

Bernard Prendergast

Close

Location

Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom

Disclaimers: 

Registration for this event will close on 15 October 2024 at 11:30pm (BST). Late registrations will not be accepted. 

The agenda is subject to change at any time  

All views expressed at this event are of the speakers themselves and not of the Royal Society of Medicine, nor the speaker's organisations.